Shin; In Sik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shin; In Sik.The latest application filed is for "composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating chronic obstructive pulmonary disease".

Company Profile

6.9.13

Shin; In Sik - Daejeon KR
Shin; In-Sik - Gwangju KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma Grant 11,135,193 - Oh , et al. October 5, 2	2021-10-05
Composition Containing Monoacetyldiglyceride Compound As Active Ingredient For Preventing Or Treating Chronic Obstructive Pulmonary Disease App 20210052536 - Oh; Sei-Ryang ; et al.	2021-02-25
Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating chronic obstructive pulmonary disease Grant 10,765,655 - Oh , et al. Sep	2020-09-08
Pharmaceutical composition comprising Pistacia weinmannifolia extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD) Grant 10,751,378 - Oh , et al. A	2020-08-25
Pharmaceutical composition for preventing or treating asthma comprising Pistacia weinmannifolia J. Poiss. ex Franch extract or fraction thereof Grant 10,413,579 - Ahn , et al. Sept	2019-09-17
Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, Magnoliae flos extract, fraction, or active fraction thereof Grant 10,376,553 - Oh , et al. A	2019-08-13
Composition Containing Monoacetyldiacylglycerol Compound As Active Ingredient For Preventing Or Treating Asthma App 20190008820 - Oh; Sei-Ryang ; et al.	2019-01-10
Method of treating chronic obstructive pulmonary disease (CPD) with verproside Grant 10,172,816 - Lee , et al. J	2019-01-08
Pharmaceutical Composition For Preventing And Treating Chronic Obstructive Lung Disease Containing, As Active Ingredient, Magnoliae Flos Extract, Fraction, Or Active Fraction Thereof App 20180353561 - OH; Sei-Ryang ; et al.	2018-12-13
Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma Grant 10,098,864 - Oh , et al. October 16, 2	2018-10-16
Composition Containing Monoacetyldiglyceride Compound As Active Ingredient For Preventing Or Treating Chronic Obstructive Pulmonary Disease App 20180280336 - OH; Sei-Ryang ; et al.	2018-10-04
Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside App 20170266142 - LEE; Yongnam ; et al.	2017-09-21
Compound isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof App 20170217982 - LEE; Yongnam ; et al.	2017-08-03
Pharmaceutical Composition For Preventing Or Treating Asthma Comprising Pistacia Weinmannifolia J. Poiss. Ex Franch Extract Or Fraction Thereof App 20170173095 - Ahn; Kyung Seop ; et al.	2017-06-22
Composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof Grant 9,655,871 - Lee , et al. May 23, 2	2017-05-23
Composition Containing Monoacetyldiglyceride Compound As Active Ingredient For Preventing Or Treating Chronic Obstructive Pulmonary Diseases App 20170042854 - OH; Sei-Ryang ; et al.	2017-02-16
Pharmaceutical Composition Comprising Pistacia Weinmannifolia Extract, Fraction Of Same Or Compound Separated From Same For Preventing Or Treating Chronic Obstructive Pulmonary Disease (copd) App 20170035822 - OH; Sei Ryang ; et al.	2017-02-09
Composition Containing Monoacetyldiacylglycerol Compound As Active Ingredient For Preventing Or Treating Asthma App 20160199339 - OH; Sei-Ryang ; et al.	2016-07-14
Mobile apparatus for executing sensing flow for mobile context monitoring, method of executing sensing flow using the same, method of context monitoring using the same and context monitoring system including the same Grant 9,367,664 - Song , et al. June 14, 2	2016-06-14
The Composition Comprising A Purified Extract Isolated From Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount Of Active Ingredient Or The Compounds Isolated Therefrom, As An Active Ingredient For Preventing Or Treating Chronic Obstructive Pulmonary Disease And The Use Thereof App 20160051612 - LEE; Yongnam ; et al.	2016-02-25
Mobile Apparatus For Executing Sensing Flow For Mobile Context Monitoring, Method Of Executing Sensing Flow Using The Same, Method Of Context Monitoring Using The Same And Context Monitoring System Including The Same App 20150106817 - SONG; June-Hwa ; et al.	2015-04-16
Scheduling Method In Multiprocessor Apparatus And Method Of Assigning Priorities To Tasks Using Pseudo-deadlines In Multiprocessor Apparatus App 20140250438 - SHIN; In-Sik ; et al.	2014-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.